메뉴 건너뛰기
Journal of Emergency Medicine
Volumn 46, Issue 5, 2014, Pages 691-692
Infliximab-induced urticaria
Author keywords

[No Author keywords available]
Indexed keywords

ANTIHISTAMINIC AGENT; INFLIXIMAB; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT;
EID: 84899485623     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2013.10.004     Document Type: Article
Times cited : (3)
References (3)
  • 1
    • 84867508021 scopus 로고    scopus 로고
    • First-line treatment in inflammatory bowel disease
    • M. Girardin, M. Manz, and C. Manser et al. First-line treatment in inflammatory bowel disease Digestion 86 Suppl. 1 2012 6 10
    • (2012) Digestion , vol.86 , Issue.SUPPL. 1 , pp. 6-10
    • Girardin, M.1    Manz, M.2    Manser, C.3
  • 2
    • 5044229341 scopus 로고    scopus 로고
    • Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: Relationship to dose, antihistamine pretreatment, and infusion number
    • M.J. Wasserman, D.A. Weber, J.A. Guthrie, V.P. Bykerk, P. Lee, and E.C. Keystone Infusion-related reactions to infliximab in patients with rheumatoid arthritis in a clinical practice setting: relationship to dose, antihistamine pretreatment, and infusion number J Rheumatol 31 2004 1912 1917
    • (2004) J Rheumatol , vol.31 , pp. 1912-1917
    • Wasserman, M.J.1    Weber, D.A.2    Guthrie, J.A.3    Bykerk, V.P.4    Lee, P.5    Keystone, E.C.6
  • 3
    • 4544313645 scopus 로고    scopus 로고
    • Managing immunogenic responses to infliximab: Treatment implications for patients with Crohn's disease
    • P.D. Han, and R.D. Cohen Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease Drugs 64 2004 1767 1777
    • (2004) Drugs , vol.64 , pp. 1767-1777
    • Han, P.D.1    Cohen, R.D.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.